PUMA BIOTECHNOLOGY, INC.: accounts_payable
| Value | {"amount": 17268000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-03-31) |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:34.551981+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e561e56d-621d-457a-ba7f-112286e4de38
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-20-022888Retrieved: 2026-08-19T13:37:34.551981+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/accounts-payable/2020-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e561e56d-621d-457a-ba7f-112286e4de38
History
- no predecessors — first report